ascorbic acid/悪性腫瘍

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the use of ascorbic acid in combination with chemotherapeutic drugs to increase the inhibitory effects of the chemotherapy and to reduce its serious side effects and the use of ascorbic acid for radioprotection in

FIELD OF THE INVENTION This invention relates generally to methods of cancer therapy and particularly the use lipoic acid as a therapeutic agent administered in combination with ascorbic acid. Ascorbate has been shown to be selectively toxic toward tumor cells, but at doses that are too high to be

FIELD OF THE INVENTION This invention relates generally to methods of cancer therapy and particularly the use lipoic acid as a therapeutic agent administered in combination with ascorbic acid. Ascorbate has been shown to be selectively toxic toward tumor cells, but at doses that are too high to be

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to new hydrophobic ascorbic ester compounds, which are synthesized by linking ascorbic acid either wit monomer prostaglandin B.sub.2 or with oligomeric derivatives of prostaglandin B.sub.2, as well as to methods of

BACKGROUND OF THE INVENTION A. Field of invention The present invention relates generally to methods of therapeutically treating cancer and more particularly to a new and improved method of administering ascorbic acid as a therapeutic agent. B. Description of Related Art In the treatment of cancer,

FILED OF THE INVENTION The present invention relates to the use of catechin compounds in combination with other dietary constituents in inhibiting matrix-metalloproteinases. More particularly, the present invention relates to the use of a composition comprising catechin, ascorbic acid, lysine and

FIELD OF THE INVENTION The present invention relates to a nutrient pharmaceutical formulation and its use for the treatment of cancer. More specifically, the present invention relates to polyphenol containing pharmaceutical formulations having an effective amount of polyphenols for the treatment of

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method and composition for treating cancer. More specifically, the present invention relates to the use of lipophilic synthetic derivatives of ascorbic acid, e.g., Ascorbyl stearate and Ascorbyl palmitate in

SUMMARY OF THE INVENTION This invention relates to a method of treating or inhibiting cancer cells in the pancreas, liver, kidney, lymph glands, salivary glands, breast, lung and stomach of humans, by administration of an alkali metal or alkaline earth metal salt of 5,6-O-benzylidene-L-ascorbic

FIELD OF THE INVENTION The present invention relates to cancer treatment. More particularly, it relates to a method for treating and curing cancer, and to compounds for use in the treatment. The present invention provides a totally new and unique approach to the identification of the primary

TECHNICAL FIELD This application relates to the area of anticancer therapeutics, more specifically, the application relates to the area of cancer immunotherapy. Specifically, the application discloses means of decreasing toxicity associated with immunotherapeutic interventions, while concurrently

BACKGROUND OF THIS INVENTION 1. Field of This Invention This invention relates to food and feed supplements. More particularly, this invention relates to food and feed supplements which are effective in retarding or delaying many biochemical and sub-cellular reactions ordinarily associated with the

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to the in vivo assessment of toxicity and pharmacokinetics of methylglyoxal and to the curative effect of the pharmaceutical composition on cancer. 2. Description of Related Art As early as 1913, it was observed that

BACKGROUND OF THE INVENTION This invention concerns a remedy against adenocarcinoma cancer, as well as a process for its production and its use. One of the greatest problems in medicine today is the combating of adenocarcinoma cancer. Despite the worldwide efforts and the very high expenditures in

1. FIELD OF INVENTION The invention relates to a novel composition of matter--trimetrexate ascorbate--and to methods of its preparation and use. The invention is further related to compositions comprising trimetrexate ascorbate, to compositions comprising trimetrexate and ascorbic acid, and to